Seattle, WA | Nov. 6-10 | Booth 502
Enjoy highlights of our genetics-focused content from this year!
Genetics & Genomics: Clinical genetic testing from Labcorp and Invitae®
Across the continuum of care, we can support you and your patients with a wide range of testing, expertise, access and counseling services. From women’s health and oncology to key clinical specialties and rare disease, our goal is to be your partner in improving health outcomes. Together, we can provide life-changing insights that support medical advancements and create a clear path to personalized care.
Don't miss our symposium: Precision Medicine in Practice: The Expanding Role of Genetic Counselors in the Rare Disease Patient Journey
This lunch symposium will bring together scientific innovation, industry and data advancements, and enhanced patient experience–highlighting how genetic counselors support the rare disease journey and impact healthcare outcomes.
Assess inherited cancer risk with Invitae’s hereditary cancer panels
Invitae® hereditary cancer panels offer comprehensive genetic testing to help assess inherited cancer risk. With analysis of over 150 genes linked to hereditary cancer syndromes, these panels support informed decision-making around personalized screening, risk-reduction strategies, and management options for patients and their families.
Inside the future of genetics: How leaders are scaling precision medicine across care settings
In this panel discussion, leaders from Swedish Cancer Institute, Labcorp, and genetics media offered their perspectives on scaling genetic services across diverse settings and preparing for the next era of precision medicine. They shared real-world strategies to expand access, streamline workflows, and strengthen collaboration across the care continuum.
Ask the expert: What your patients need to know about working with a genetic counselor
Preparing for a genetic counseling session can seem overwhelming for patients. We interviewed Michaela, who answers common questions and provides helpful information for patients to help guide them through the genetic counseling process.
Upcoming Webinar
Better Together: Exploring the Synergy of Germline and Somatic Testing for Treating and Managing Cancer
Tuesday, November 4, 10 a.m. PT / 1 p.m. ET
This session will explore how somatic and germline genetic testing in oncology can enable more comprehensive insights into cancer biology and treatment. Traditionally, these two testing modalities have been performed independently, limiting the scope of data that can inform clinical decisions. We aim to demonstrate the clinical utility of integrating somatic and germline data to guide therapeutic decisions, particularly for cancers where germline and somatic variants influence treatment.
Watch our webinar series on variant interpretation
The importance of human expertise: genetic testing from sample to report
Take a look into the critical role of scientists at each stage of the process, including sample processing, sequencing, data analysis, variant classification and report generation. Learn how automation enhances efficiency and consistency, while expert human oversight ensures each result is accurate, reliable, and clinically meaningful.
The importance of human expertise in AI-informed variant interpretation workflows
We explore how AI is helping leverage diverse data sources to improve classification confidence and reduce rates of variants of uncertain significance (VUS). We compare the impact of machine learning-driven insights versus traditional evidence, and how expert oversight ensures that these innovations translate into meaningful clinical outcomes.
Making sense of MAVEs: how machine learning and human expertise are improving variant classification and clinical actionability
Learn how multiplexed assays of variant effect (MAVEs) produce high-throughput functional data, and how machine learning models standardize, validate and integrate those data into germline variant classification. MAVE-based models can be incorporated to reclassify variants, reduce variants of uncertain significance (VUS) and enhance clinical actionability.
Have questions for us before the show?
Contact your Labcorp representative or our client services team by submitting an online form
